CAT vs TERN · P/E 48, rev $20.54B vs $6.12B cap
Caterpillar Inc (CAT) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CAT and TERN stock pages for the full models.
Not investment advice.